Companies: 10,795·Total market cap: $144.5T
Amgen Inc.

Amgen Inc.

AMGNNASDAQHealthcare● Active
$344.80
$-4.78(-1.37%)
Market Cap$186.1B
P/E Ratio—
52W High$391.29
52W Low$267.83
Overview

Amgen Inc. (AMGN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000318154 · AMGN · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,011+
Total Filings
4
Latest Form
2026-05-21
Most Recent
1983
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000318154 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-13
Fiscal Year End
Feb 13, 2026
Accession No.
0000318154-26-000010
Primary Document
amgn-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000318154 · Accession 0000318154-26-000010

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-01
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-20Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-20
View
8-KCurrent Report
8-K
2026-05-19
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-14
View
10-QQuarterly Report
10-Q
2026-05-01
View
8-KCurrent Report
8-K
2026-04-30
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
8-KCurrent Report
8-K
2026-04-22
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-21
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-15
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-07
View
DEF 14AProxy Statement
DEF 14A
2026-04-07
View
ARSARS
ARS
2026-03-31
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
25-NSE25-NSE
25-NSE
2026-02-24
View
8-KCurrent Report
8-K
2026-02-19
View
Showing 1–15 of 303 filingsForm 4 / 144 hidden· 1011 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000318154  |  Exchange: NASDAQ · Healthcare

Amgen Inc. (NASDAQ: AMGN) has submitted 1,011+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1983. As a Healthcare sector company with CIK 0000318154, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Amgen Inc.'s most comprehensive regulatory disclosure. The most recent Amgen Inc. 10-K was filed on 2026-02-13 for fiscal year ending 2026. Historical AMGN 10-K annual reports are available from 2018 through 2026.

Investors researching Amgen Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
MRK SEC Filings →NVS SEC Filings →NVO SEC Filings →GILD SEC Filings →PFE SEC Filings →DHR SEC Filings →BMY SEC Filings →SNY SEC Filings →
→ AMGN Financials→ AMGN Earnings→ AMGN Insider Trades

Frequently Asked Questions

AMGN SEC Filings · 8 questions

Amgen Inc. (AMGN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,011+ filings and access original documents at no cost. Amgen Inc.'s CIK is 0000318154.

AMGN SEC filingsAmgen Inc. SEC documentsfind AMGN 10-K